While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Concerns about bird flu are growing among health officials weeks after the first person in the U.S. died from the virus, and ...

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

As bird flu continues to threaten animals and public health, the U.S. government has stepped up its response. Experts says it ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

A new strain of bird flu has been detected in the United States, and it has sparked a lot of concerns among farmers and ...

Robert F. Kennedy Jr.'s views on vaccines and his nomination for HHS secretary were questioned again in a second Senate hearing.

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory ... along with a seasonal influenza candidate also in phase 2 and one for avian influenza in phase ...

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of ...